Maplight Therapeutics Inc (MPLT)

SG&A Expenses

$43.78M

TTM · Period ending: · USD

MPLT logo

MPLT SG&A Expenses

Latest reported$43.78M
MPLT TTM SG&A Expenses ($13.98M → $43.78M)
High-resolution chart · PNG

MPLT sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Maplight Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
43,781,000
37,632,000
30,731,000
14,041,000
13,717,000
14,243,000
14,431,000
13,984,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.